JCOIN Speaker Series: Key Barriers and Facilitators for Medications to Treat Opioid Use Disorders in U.S. Jails

While previous studies examine the availability of medications for opioid use disorder (MOUD) in jails and the barriers to using these medications, much less is known about how to incorporate best practices for addressing opioid use disorder (OUD) in jails. Determining the best practices involves considering the necessary training, resources, and technical assistance for providing MOUD. In response to this urgent need, researchers with JCOIN’s Clinical Research Center at Chestnut Health Systems conducted a national study to understand the OUD best practices in jails located in counties heavily impacted by opioid overdose in the U.S. and their resource and training needs.

This webinar presented findings from the national study, including the identification of 10 OUD best practices that were consistently referenced in treatment and practice guidelines recommended by a variety of federal agencies and national organizations, and were grounded in the scientific literature. Presenters also shared insights from study sites on critical barriers that impede the implementation and expansion of MOUD in the criminal legal system and facilitators to support and provide evidence-based services to individuals with OUD who come in contact with the legal system.

Speakers:

  • Christine Grella, Ph.D., Senior Researcher, Lighthouse Institute, Chestnut Health Systems
  • Tisha Wiley, Ph.D., Branch Chief, Associate Director for Justice Systems, National Institute on Drug Abuse (NIDA)

View the full webinar
View the slides


This webinar was based on the findings from the following study:
Scott, C. K., Grella, C. E., Dennis, M. L., Carnevale, J., & LaVallee, R. (2022). Availability of best practices for opioid use disorder in jails and related training and resource needs: findings from a national interview study of jails in heavily impacted counties in the U.S. Health & justice, 10(1), 36. https://doi.org/10.1186/s40352-022-00197-3